Teva Pharmaceutical Industries Ltd (TEVA)
17.09
+0.06
(+0.35%)
USD |
NYSE |
Nov 21, 11:36
Teva Pharmaceutical Industries Price: 17.09 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 16.90 | 17.16 | 16.80 | 17.03 | 6.262M |
| Nov 19, 2024 | 16.43 | 16.86 | 16.39 | 16.81 | 7.146M |
| Nov 18, 2024 | 16.41 | 16.50 | 16.15 | 16.49 | 8.186M |
| Nov 15, 2024 | 16.22 | 16.63 | 16.16 | 16.43 | 8.734M |
| Nov 14, 2024 | 16.82 | 16.93 | 16.58 | 16.75 | 9.548M |
| Nov 13, 2024 | 17.11 | 17.17 | 16.94 | 16.94 | 4.650M |
| Nov 12, 2024 | 17.38 | 17.50 | 17.02 | 17.11 | 7.403M |
| Nov 11, 2024 | 17.40 | 17.51 | 17.14 | 17.37 | 7.463M |
| Nov 08, 2024 | 17.41 | 17.50 | 17.07 | 17.11 | 6.225M |
| Nov 07, 2024 | 17.63 | 17.86 | 17.43 | 17.50 | 11.52M |
| Nov 06, 2024 | 19.06 | 19.31 | 17.18 | 17.43 | 18.21M |
| Nov 05, 2024 | 18.64 | 18.79 | 18.48 | 18.77 | 5.036M |
| Nov 04, 2024 | 18.53 | 18.80 | 18.38 | 18.64 | 7.092M |
| Nov 01, 2024 | 18.44 | 18.73 | 18.36 | 18.45 | 7.100M |
| Oct 31, 2024 | 18.25 | 18.47 | 18.23 | 18.44 | 6.882M |
| Oct 30, 2024 | 18.42 | 18.74 | 18.20 | 18.59 | 6.343M |
| Oct 29, 2024 | 18.26 | 18.48 | 18.22 | 18.43 | 7.682M |
| Oct 28, 2024 | 18.02 | 18.40 | 17.97 | 18.37 | 3.978M |
| Oct 25, 2024 | 18.25 | 18.39 | 17.85 | 17.90 | 5.126M |
| Oct 24, 2024 | 18.50 | 18.56 | 18.20 | 18.25 | 5.480M |
| Oct 23, 2024 | 18.40 | 18.46 | 18.16 | 18.41 | 4.292M |
| Oct 22, 2024 | 18.09 | 18.46 | 17.97 | 18.38 | 3.720M |
| Oct 21, 2024 | 18.04 | 18.41 | 18.02 | 18.18 | 4.872M |
| Oct 18, 2024 | 17.96 | 18.02 | 17.73 | 17.95 | 3.606M |
| Oct 17, 2024 | 18.08 | 18.18 | 17.89 | 17.96 | 3.096M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.69
Minimum
Mar 18 2020
18.96
Maximum
Sep 04 2024
10.68
Average
9.86
Median
Dec 16 2019
Price Benchmarks
| Amicus Therapeutics Inc | 9.51 |
| Compugen Ltd | 1.46 |
| Pluri Inc | 4.82 |
| Can Fite Biofarma Ltd | 2.03 |
| BiomX Inc | 0.508 |
Price Related Metrics
| PS Ratio | 1.148 |
| Price to Book Value | 3.193 |
| Price to Free Cash Flow | 14.08 |
| Earnings Yield | -4.97% |
| Market Cap | 19.36B |
| Operating PE Ratio | 5.166 |
| Normalized PE Ratio | 11.11 |